| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S1368-7646(03)00041-4 |
| P698 | PubMed publication ID | 12860461 |
| P50 | author | Ian Chopra | Q105819967 |
| Keith Miller | Q40739161 | ||
| P2093 | author name string | Alexander J O'Neill | |
| P2860 | cites work | Does selective gene activation direct evolution? | Q41334517 |
| Selection against hypermutability in Escherichia coli during long term evolution | Q41568929 | ||
| Lack of evidence for involvement of hypermutability in emergence of vancomycin-intermediate Staphylococcus aureus | Q42859651 | ||
| The ability of certain antimutagenic agents to prevent development of antibiotic resistance | Q43733566 | ||
| A hypermutator phenotype attenuates the virulence of Listeria monocytogenes in a mouse model | Q43982282 | ||
| Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. | Q44012036 | ||
| The role of the stringent response in the pathogenesis of bacterial infections. | Q44087986 | ||
| Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair | Q46617407 | ||
| Effects of antimutagens on development of drug/antibiotic resistance in microorganisms | Q47798689 | ||
| High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
| Antimutagenic and anticarcinogenic activity of tea polyphenols | Q50128098 | ||
| Detection of mutator subpopulations in Salmonella typhimurium LT2 by reversion of his alleles | Q50130080 | ||
| The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants | Q50192890 | ||
| Bacterial resistance: origins, epidemiology, and impact. | Q52282006 | ||
| Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is low. | Q52861291 | ||
| Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. | Q54073909 | ||
| A conspicuous adaptability to antibiotics in the Escherichia coli mutator strain, dnaQ49. | Q54085756 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| Costs and Benefits of High Mutation Rates: Adaptive Evolution of Bacteria in the Mouse Gut | Q56944626 | ||
| The effect of the stringent response on mutation rates in Escherichia coli K-12 | Q71577046 | ||
| Predicting the emergence of antibiotic resistance by directed evolution and structural analysis | Q27630116 | ||
| The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants | Q28492576 | ||
| Mismatch repair in replication fidelity, genetic recombination, and cancer biology | Q29616483 | ||
| Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG | Q29616532 | ||
| Mut-Test to detect substances suppressing spontaneous mutation due to oxidative damage | Q31817614 | ||
| Escherichia coli mutator genes | Q33539352 | ||
| cAMP-dependent SOS induction and mutagenesis in resting bacterial populations. | Q33719467 | ||
| Hypermutation in bacteria and other cellular systems | Q33770256 | ||
| Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori | Q33952076 | ||
| Mutator clones of Neisseria meningitidis in epidemic serogroup A disease | Q34028018 | ||
| Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance | Q34102811 | ||
| Mutator bacteria as a risk factor in treatment of infectious diseases | Q34113782 | ||
| An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus | Q34142416 | ||
| New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy | Q34192597 | ||
| Low-level antibacterial resistance: a gateway to clinical resistance | Q34341270 | ||
| Evolution of high mutation rates in experimental populations of E. coli | Q34429727 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50. | Q34508887 | ||
| The fate of microbial mutators | Q34623647 | ||
| Why are bacteria refractory to antimicrobials? | Q34921763 | ||
| The future challenges facing the development of new antimicrobial drugs. | Q34988239 | ||
| Proliferation of mutators in A cell population | Q35618973 | ||
| Negative regulation of mutS and mutH repair gene expression by the Hfq and RpoS global regulators of Escherichia coli K-12. | Q35633546 | ||
| Genetic systems in staphylococci | Q36439616 | ||
| Anaerobic infections of the urinary tract: are they being missed? | Q37227372 | ||
| The frequency of mutators in populations of Escherichia coli | Q38304923 | ||
| Bacillus subtilis mutS mutL operon: identification, nucleotide sequence and mutagenesis | Q38354717 | ||
| Phylogenetic evidence for horizontal transfer of mutS alleles among naturally occurring Escherichia coli strains | Q39502754 | ||
| Genetic antagonism and hypermutability in Mycobacterium smegmatis | Q39538622 | ||
| Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations | Q39651266 | ||
| High frequency of mutator strains among human uropathogenic Escherichia coli isolates. | Q39694657 | ||
| Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation. | Q39743496 | ||
| Depletion of the cellular amounts of the MutS and MutH methyl-directed mismatch repair proteins in stationary-phase Escherichia coli K-12 cells | Q39841075 | ||
| Carbon starvation of Salmonella typhimurium does not cause a general increase of mutation rates | Q39847729 | ||
| Inactivation of antibiotics and the dissemination of resistance genes | Q40737331 | ||
| P433 | issue | 3 | |
| P921 | main subject | bacteria | Q10876 |
| antibiotic resistance | Q380775 | ||
| P304 | page(s) | 137-145 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Drug Resistance Updates | Q3040081 |
| P1476 | title | The role of mutators in the emergence of antibiotic-resistant bacteria | |
| P478 | volume | 6 |
| Q28474039 | A reservoir of drug-resistant pathogenic bacteria in asymptomatic hosts |
| Q36344782 | A single nucleotide change in mutY increases the emergence of antibiotic-resistant Campylobacter jejuni mutants |
| Q35816112 | Acinetobacter baumannii Repeatedly Evolves a Hypermutator Phenotype in Response to Tigecycline That Effectively Surveys Evolutionary Trajectories to Resistance |
| Q39895301 | Activity of linezolid in an in vitro pharmacokinetic-pharmacodynamic model using different dosages and Staphylococcus aureus and Enterococcus faecalis strains with and without a hypermutator phenotype |
| Q36596823 | Adaptation to Parasites and Costs of Parasite Resistance in Mutator and Nonmutator Bacteria |
| Q40230898 | Adaptive tuning of mutation rates allows fast response to lethal stress in Escherichia coli |
| Q99555879 | Antibiotic Resistance Characteristics of Pseudomonas aeruginosa Isolated from Keratitis in Australia and India |
| Q41937031 | Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system. |
| Q38185117 | Antibiotrophs: The complexity of antibiotic-subsisting and antibiotic-resistant microorganisms. |
| Q37356533 | Antimicrobial resistance: its emergence and transmission |
| Q37794342 | Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance |
| Q35701625 | Can better prescribing turn the tide of resistance? |
| Q41988982 | Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC |
| Q33418487 | Cyclic-di-GMP signalling and biofilm-related properties of the Shiga toxin-producing 2011 German outbreak Escherichia coli O104:H4. |
| Q36754647 | DNA damage regulation and its role in drug-related phenotypes in the malaria parasites |
| Q38898545 | Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents |
| Q40968218 | Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion |
| Q42370976 | Detection of hypermutable Escherichia coli strains in a collection of clinical isolates by the fosfomycin-rifampin disk method. |
| Q49982300 | Distribution and Molecular Characterization of Salmonella enterica Hypermutators in Retail Food in China |
| Q50056870 | Distribution of mutation frequencies among Salmonella enterica isolates from animal and human sources and genetic characterization of a Salmonella Heidelberg hypermutator |
| Q36178618 | Diversify or die: generation of diversity in response to stress. |
| Q45962906 | DnaN clamp zones provide a platform for spatiotemporal coupling of mismatch detection to DNA replication. |
| Q90148668 | Dynamic Emergence of Mismatch Repair Deficiency Facilitates Rapid Evolution of Ceftazidime-Avibactam Resistance in Pseudomonas aeruginosa Acute Infection |
| Q50077962 | Effect of exposure to fluoroquinolones and beta-lactams on the in vitro activity of other groups of antibiotics in Salmonella spp. |
| Q41773256 | Effects of subinhibitory concentrations of antibiotics on SOS and DNA repair gene expression in Staphylococcus aureus |
| Q37896674 | Emergence and spread of antibiotic resistance following exposure to antibiotics |
| Q40410503 | Escherichia coli mutators present an enhanced risk for emergence of antibiotic resistance during urinary tract infections |
| Q52707803 | Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care. |
| Q54949785 | Experimental evolution of resistance to an antimicrobial peptide. |
| Q35130454 | Exposure to phages has little impact on the evolution of bacterial antibiotic resistance on drug concentration gradients |
| Q38414823 | Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health |
| Q39990097 | Fosfomycin and rifampin disk diffusion tests for detection of Escherichia coli mutator strains |
| Q95840911 | Genes and Proteomes Associated With Increased Mutation Frequency and Multidrug Resistance of Naturally Occurring Mismatch Repair-Deficient Salmonella Hypermutators |
| Q47588437 | High frequency plasmid recombination mediated by 28 bp direct repeats |
| Q42054872 | High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae. |
| Q42261855 | High-fidelity DNA replication in Mycobacterium tuberculosis relies on a trinuclear zinc center. |
| Q36667671 | Hypermutable Pseudomonas aeruginosa in Cystic fibrosis patients from two Brazilian cities. |
| Q44350722 | Hypermutable Staphylococcus aureus strains present at high frequency in subclinical bovine mastitis isolates are associated with the development of antibiotic resistance |
| Q33770211 | Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus |
| Q37922538 | Hypermutation and stress adaptation in bacteria |
| Q41974061 | Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections |
| Q34933382 | Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance |
| Q39609549 | Increased mutation frequencies in Escherichia coli isolates harboring extended-spectrum beta-lactamases |
| Q39955018 | Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients |
| Q34057563 | Long-term dissemination of CTX-M-5-producing hypermutable Salmonella enterica serovar typhimurium sequence type 328 strains in Russia, Belarus, and Kazakhstan |
| Q36756563 | Lytic phages obscure the cost of antibiotic resistance in Escherichia coli |
| Q36733020 | Mechanisms of resistance in bacteria: an evolutionary approach |
| Q28597450 | Methylated Cytosines Mutate to Transcription Factor Binding Sites that Drive Tetrapod Evolution |
| Q41849601 | Mismatch correction modulates mutation frequency and pilus phase and antigenic variation in Neisseria gonorrhoeae |
| Q34660590 | Mismatch repair causes the dynamic release of an essential DNA polymerase from the replication fork |
| Q36728061 | Mutant selection window hypothesis updated. |
| Q92752649 | Mutation rate variability as a driving force in adaptive evolution |
| Q46274173 | Mutator genomes decay, despite sustained fitness gains, in a long-term experiment with bacteria |
| Q41825397 | Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation |
| Q50044377 | Optimization of a meropenem plus tobramycin combination dosage regimen against hypermutable and non-hypermutable Pseudomonas aeruginosa via mechanism-based modeling and the hollow-fiber infection model. |
| Q34426663 | Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms. |
| Q39606842 | Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations. |
| Q28273315 | Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques |
| Q40738359 | Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance |
| Q36421553 | Pseudomonas aeruginosa RsmA plays an important role during murine infection by influencing colonization, virulence, persistence, and pulmonary inflammation |
| Q36478473 | Pseudomonas aeruginosa infection among cystic fibrosis and ICU patients in the referral children medical hospital in Tehran, Iran |
| Q40166144 | Rapid and Consistent Evolution of Colistin Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa during Morbidostat Culture |
| Q37716243 | Rate and effects of spontaneous mutations that affect fitness in mutator Escherichia coli |
| Q36276354 | Residues in the N-terminal domain of MutL required for mismatch repair in Bacillus subtilis |
| Q38793887 | Role of Phenothiazines and Structurally Similar Compounds of Plant Origin in the Fight against Infections by Drug Resistant Bacteria |
| Q40968026 | Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype |
| Q26991866 | Staphylococcal response to oxidative stress |
| Q24625342 | Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis |
| Q42572942 | Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa |
| Q92857979 | The Mutator Phenotype: Adapting Microbial Evolution to Cancer Biology |
| Q44959184 | The effects of plant extracts on microbial community structure in a rumen-simulating continuous-culture system as revealed by molecular profiling |
| Q22065663 | The emergence of antibiotic resistance by mutation |
| Q30043983 | The role of DNA mismatch repair in generating genetic diversity and drug resistance in malaria parasites |
| Q35492470 | Variable numbers of tandem repeats in Plasmodium falciparum genes |
Search more.